ArticleBlood advances2025
Genetic deregulation of REL in germinal center B cells induces generation of a pool of lymphoma precursor cells.
Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mouse models of B cell lymphomas on the basis of genetic features.Frontiers in immunology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractIn diffuse large B-cell lymphomas (DLBCLs), gains and amplifications of the 2p15-16 region, which always encompass the REL gene, are mostly restricted to the germinal center (GC) B-cell DLBCL subtype (GCB-DLBCL) for which c-Rel is the pivotal Rel/NF-κΒ subunit. Although REL plays a key role in the GC reaction, its contribution to GCB-DLBCLs remains unclear.To understand the role of REL in the very first steps of GCB transformation, that is, when B cells with deregulated REL are competing with other B cells during chronic antigenic stimulation, we have created a dual-color mouse model that allows to induce REL in a limited pool of activation-induced cytidine deaminase (AID)-imprinted B cells after immunization and to differentially stain AID-imprinted B cells that overexpress REL or not. Dysregulation of REL in AID-imprinted B cells was associated with nuclear c-Rel overexpression in GCs 14 days after immunization. Dysregulation of REL at the GCB stage promoted GCB expansion, which was associated with both class-switch recombination and plasma cell differentiation. REL overexpression conferred a long-term competitive advantage, allowing GC persistence and continuous recirculation of REL-overexpressing B cells. IgHV dominance was increased at the messenger RNA level in REL-overexpressing B cells and clonal expansion was detected at the DNA level in some cases. Highlighting the role of the immune response, our results demonstrate the advantage conferred by REL in the GC competition and provide evidence that, as an oncogenic event of GCBs, its genetic deregulation induces the generation of a long-term pool of lymphoma precursor cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.